
Genome Valley Pharma Parks And Incubators Private Limited
Develops specialized infrastructure for pharma, biotech, CROs, CDMOs, agri, and med-tech companies.
Develops specialized infrastructure for pharma, biotech, CROs, CDMOs, agri, and med-tech companies.
Genome Valley Pharma Parks And Incubators Private Limited (GVPPAIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2021 (Three years and 11 months 14 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.10 Cr and a paid-up capital of Rs 30.00 Cr.
The company currently has active open charges totaling ₹285.00 Cr.
The Key Managerial Personnel (KMP) at Genome Valley Pharma Parks And Incubators Private Limited India is Yashi Gupta as COMPANY SECRETARY. Ashish Singh, Milind Ravi, Raghvendra Chandak, and One other member serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24290TG2021PTC152164
152164
Private Limited Indian Non-Government Company
10 Jun 2021
21 Aug 2023
31 Mar 2023
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yashi Gupta | Company Secretary | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Milind Ravi ![]() | Director | 10-Jun-2021 | Current |
Ashish Singh ![]() | Director | 09-Dec-2022 | Current |
Raghvendra Chandak ![]() | Director | 09-Dec-2022 | Current |
Praveen Sridharan ![]() | Director | 09-Dec-2022 | Current |
Genome Valley Pharma Parks And Incubators Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 834.83% decrease in profit. The company's net worth Soared by an impressive increase of 109882.94%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Genome Valley Pharma Parks And Incubators had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ashish Singh, Milind Ravi and 2 more are mutual person
Ashish Singh is a mutual person
Ashish Singh is a mutual person
Ashish Singh, Raghvendra Chandak and 1 more are mutual person
Ashish Singh and Raghvendra Chandak are mutual person
Ashish Singh is a mutual person
₹285.00 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
29 Nov 2023 | Axis Bank Limited | ₹285.00 Cr | Open |
Genome Valley Pharma Parks And Incubators has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genome Valley Pharma Parks And Incubators, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genome Valley Pharma Parks And Incubators's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited of Rs. 285.00 Cr registered on 29 Nov 2023 with Charge ID 100837689 was modified on 12 Mar 2024.
A charge with Axis Bank Limited amounted to Rs. 285.00 Cr with Charge ID 100837689 was registered on 29 Nov 2023.
Genome Valley Pharma Parks And Incubators Private Limited last Annual general meeting of members was held on 21 Aug 2023 as per latest MCA records.
Genome Valley Pharma Parks And Incubators Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
Ashish Balram Singh was appointed as a Director was appointed as a Director on 09 Dec 2022 & has been associated with this company since 2 years 5 months .
Raghvendra Chandak was appointed as a Director was appointed as a Director on 09 Dec 2022 & has been associated with this company since 2 years 5 months .
Genome Valley Pharma Parks And Incubators Private Limited was incorporated on 10 Jun 2021.
The authorized share capital of Genome Valley Pharma Parks And Incubators Private Limited is ₹ 30.10 Cr and paid-up capital is ₹ 30.00 Cr.
Currently 5 directors are associated with Genome Valley Pharma Parks And Incubators Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Genome Valley Pharma Parks And Incubators Private Limited is Sy.No.403/1(Old) 120(New) 4Th Floor Niharika Jubilee One Road No.1 Hills, India, Hyderabad, Telangana, 500033.
The corporate identification number (CIN) of Genome Valley Pharma Parks And Incubators Private Limited is U24290TG2021PTC152164 and the company number is 152164 as per Ministry of Corporate Affairs (MCA).
The financial reports for the fiscal year 2023 indicates that The net worth of Genome Valley Pharma Parks And Incubators Private Limited has experienced an upsurge of 109882.94%.
As per the financial statements for fiscal Year 2023, The total open charges for Genome Valley Pharma Parks And Incubators Private Limited amount to ₹ 285.00 Cr.
The most recent Balance Sheet for Genome Valley Pharma Parks And Incubators Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
PB